A study of 99mtechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers

No abstract is available for this paper.

• Publication year

  1995

• Venue

  International Journal of Pharmaceutics

• Publication date

  1995-03-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0378-5173(94)00265-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The deposition and clearance of liposome entrapped 99mTc-DTPA in the human respiratory tract

  1994cited by this paper
• Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol.

  1994cited by this paper
• Nebulized Glucocorticoids in Liposomes: Aerosol Characteristics and Human Dose Estimates

  1994cited by this paper
• Pulmonary delivery of liposomes

  1993cited by this paper
• The relationship between inflammation and hyperreactivity of the airways in asthma

  1993cited by this paper
• Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function.

  1993cited by this paper
• Liposomes for drug delivery to the respiratory tract

  1993cited by this paper
• Cyclosporin A liposome aerosol: Particle size and calculated respiratory deposition

  1993cited by this paper
• International Consensus Report on Diagnosis and Treatment of Asthma.

  1992cited by this paper
• Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids.

  1992cited by this paper
• Determination of phosphatidylcholine phosphatidylglycerol and their lyso forms from liposome dispersions by high performance liquid chromatography using high sensitivity refractive index detection

  1991cited by this paper
• Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation.

  1987cited by this paper
• 99m-technetium as a marker of liposomal deposition and clearance in the human lung

  1985cited by this paper
• A technique for the absolute measurement of activity using a gamma camera and computer

  1979cited by this paper
• The collison nebulizer: Description, performance and application

  1973cited by this paper
• Morphometry of the Human Lung

  1965cited by this paper

• Ambient Particulate Matter Induces In Vitro Toxicity to Intestinal Epithelial Cells without Exacerbating Acute Colitis Induced by Dextran Sodium Sulfate or 2,4,6-Trinitrobenzenesulfonic Acid

  2024cites this paper
• Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: previous strategies, recent advances and key factors description.

  2023cites this paper
• Particulate Matter Induces Tissue OxInflammation: From Mechanism to Damage

  2020cites this paper
• Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis

  2020cites this paper
• Cellulose-Based Hydrogels for Pharmaceutical and Biomedical Applications

  2018cites this paper
• Diseases of the Digestive System and Air Pollution

  2018cites this paper
• Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases

  2017cites this paper
• Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer.

  2016cites this paper
• Pulmonary delivery of anti-inflammatory agents

  2015cites this paper
• Stability-indicating RP-HPLC method for determination of beclomethasone dipropionate in nanocapsule suspensions

  2015influential citation
• Polluted Air Quality Component Analysis from Stack Emission and its Hazardous Consequences on Human Health

  2015cites this paper
• Lipid-based carriers for pulmonary products: preclinical development and case studies in humans.

  2014cites this paper
• Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.

  2014cites this paper
• 99mTc-labeled therapeutic inhaled amikacin loaded liposomes

  2013cites this paper
• Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases

  2013cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology

  2011cites this paper
• Preparation of spray-dried microparticles using Gelucire 44/14 and porous calcium silicate or spherical microcrystalline cellulose to enhance transport of water-insoluble pranlukast hemihydrate across Caco-2 monolayers

  2011cites this paper
• Air pollution: An environmental factor contributing to intestinal disease.

  2011cites this paper
• Development and characterisation of freeze-dried liposomes containing two anti-asthma drugs

  2010cites this paper
• A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers

  2009cites this paper
• Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.

  2008cites this paper
• Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.

  2008cites this paper
• Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

  2008cites this paper
• Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.

  2008cites this paper
• Disease guided optimization of the respiratory delivery of microparticulate formulations

  2008cites this paper
• Dipropionato de beclometasona em formulação lipossomal como po inalavel para o tratamento de doenças pulmonares

  2007cites this paper
• One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier.

  2007cites this paper
• Amphiphilic triblock copolymer poly(p-dioxanone-co-L-lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery

  2007cites this paper
• Drug targeting delivery systems for treatment of Raf-1 induced lung tumors in mice

  2007cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS

  2006cites this paper
• The use of sterically stabilized liposomes to treat asthma.

  2005cites this paper
• Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy

  2005cites this paper
• Expulsion of bovine serum albumin from the air/water interface by a sparingly soluble lecithin lipid.

  2004cites this paper
• Efficacy of liposomal budesonide in experimental asthma.

  2003cites this paper
• Pulmonary administration of IgG loaded liposomes for passive immunoprophylaxy.

  2003cites this paper
• No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer.

  2003cites this paper
• Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes.

  2001cites this paper
• In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.

  2001cites this paper
• Aerosol Characterization of Nebulized Intranasal Glucocorticoid Formulations

  2001cites this paper
• Pharmacokinetic Considerations in the Design of Pulmonary Drug Delivery Systems for Glucocorticoids

  2001cites this paper
• The measurement of beclomethasone dipropionate entrapment in liposomes: a comparison of a microscope and an HPLC method.

  2001cites this paper
• 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.

  2000cites this paper
• Biochemical efficacy evaluation of the liposomal forms of fenoterol in rats with bronchial obstruction

  2000cites this paper
• 9‐Nitrocamptothecin Liposome Aerosol Treatment of Human Cancer Subcutaneous Xenografts and Pulmonary Cancer Metastases in Mice

  2000cites this paper
• Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery.

  2000cites this paper
• Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol interpolymer complex with various cross-linking degrees of Carbopol.

  2000cites this paper
• Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.

  1999cites this paper
• Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.

  1999cites this paper
• Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

  1999cites this paper
• Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression.

  1999cites this paper
• Aerosol delivery of liposomal all-trans -retinoic acid to the lungs

  1999cites this paper
• Stabilization of aerosolized IFN-γ by liposomes

  1999cites this paper
• Control of medicine release from solid dispersion composed of the poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly(ethylene oxide).

  1999cites this paper
• Effect of Dose and Release Rate on Pulmonary Targeting of Liposomal Triamcinolone Acetonide Phosphate

  1998cites this paper
• Pulmonary pharmacokinetics of cyclosporin A liposomes

  1998cites this paper
• Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.

  1998cites this paper
• CHAPTER 6.3 – Pulmonary applications of liposomes

  1998cites this paper
• Experimental pulmonary delivery of cyclosporin A by liposome aerosol

  1998cites this paper
• Control of medicine release from solid dispersion through poly(ethylene oxide)-carboxyvinylpolymer interaction

  1998cites this paper
• Nebulisers for the generation of liposomal aerosols

  1998cites this paper
• Mechanism of medicine release from solid dispersion composed of poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex and pH effect on medicine release

  1998cites this paper
• Nebulized Interleukin 2 Liposomes: Aerosol Characteristics and Biodistribution

  1997cites this paper
• Ultrasonic nebulisers for pulmonary drug delivery

  1997cites this paper
• Effect of Aerosol Delivery System and Formulation on Nebulized Budesonide Output

  1997cites this paper
• High dose cyclosporin A and budesonide-liposome aerosols

  1997cites this paper
• Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety.

  1997cites this paper
• Jet nebulisers for pulmonary drug delivery

  1996cites this paper
• Liposomal Aerosols in the Management of Pulmonary Infections

  1996cites this paper
• The stability of liposomes to ultrasonic nebulisation

  1996cites this paper
• Pulmonary delivery of antiviral drugs in liposome aerosols

  1996cites this paper
• Liposomal DNA vectors for cystic fibrosis gene therapy. Current applications, limitations, and future directions

  1996cites this paper
• Delivery of DNA–Cationic Liposome Complexes by Small-Particle Aerosol

  1996cites this paper
• Pulmonary Targeting of Liposomal Triamcinolone Acetonide Phosphate

  1996cites this paper
• Pulmonary Delivery of Liposome-Encapsulated Drugs in Asthma Therapy

  1995cites this paper